Metabolic Solutions Raises $10 Million
Published: May 13, 2009
PEH -- Metabolic Solutions Development Co., a Kalamazoo, Mich.-based developer of drugs to treat Type II diabetes, has raised $9.25 million in new VC funding. According to VentureWire, investors include Hopen Therapeutics and Southwest Michigan First Life Science. The company also secured $1.36 million in grants from the National Institutes of Health.